ArticleVeterinary world2025
Deciphering the anticoccidial mechanism of Qinghao Changshan formula through network pharmacology and molecular docking.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Coccidiosis is a widespread protozoan disease that severely impacts poultry health and productivity. The Qinghao Changshan (QHCS) formula, composed of multiple traditional Chinese medicinal herbs, is widely used in China for coccidiosis control. Despite its proven clinical efficacy, the molecular mechanisms underlying its therapeutic action remain poorly understood. This study aimed to elucidate the active components and molecular mechanisms of QHCS against coccidiosis using an integrated approach combining network pharmacology and molecular docking. Materials and Methods: Active compounds of QHCS were identified from public pharmacological databases based on criteria of oral bioavailability ≥ioa and drug-likeness ≥rug-l Targets of these compounds were predicted using SwissTargetPrediction and PharmMapper, and disease-related genes were retrieved from GeneCards, DrugBank, OMIM (Online Mendelian Inheritance in Man), and Therapeutic Target Database. Overlapping targets were visualized using Venn diagrams, and protein-protein interaction (PPI) networks were constructed using STRING and Cytoscape. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted to explore relevant biological functions and pathways. Molecular docking was used to validate interactions between selected active compounds (isorhamnetin, kaempferol, quercetin) and key targets (epidermal growth factor receptor [EGFR], estrogen receptor 1 [ESR1], progesterone receptor [PGR]). Results: Sixty-nine active compounds and 3476 potential targets of QHCS were identified, with 11 targets overlapping with 87 coccidiosis-related genes. Eight core targets-Amyloid Beta Precursor Protein, interleukin 6, TNF Receptor Associated Factor 1, Platelet Derived Growth Factor Receptor Beta, EGFR, ESR1, Erb-B2 Receptor Tyrosine Kinase 2, and PGR-were identified through PPI network analysis. GO and KEGG enrichment revealed key pathways including focal adhesion, calcium signaling, mitogen-activated protein kinase, ErbB signaling pathway, forkhead box O, and gap junction pathways. Molecular docking confirmed strong binding affinities of isorhamnetin, kaempferol, and quercetin to EGFR, ESR1, and PGR, supporting their regulatory roles in these signaling pathways. Conclusion: QHCS exhibits anti-coccidial activity by modulating multiple signaling pathways and molecular targets through its key bioactive constituents. These findings provide mechanistic insights into the therapeutic effects of QHCS and lay a theoretical foundation for its broader application in veterinary parasitology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.